Dissecting DNA hypermethylation in cancer

Marcos R H Estécio1, Jean-Pierre J Issa

  • 1Department of Leukemia, UT MD Anderson Cancer Center, Houston, TX 77030, United States. mestecio@mdanderson.org

FEBS Letters
|December 15, 2010
PubMed

Insights

DNA methylation alterations are crucial in cancer, with both gains and losses impacting gene expression. Aberrant DNA methylation arises from a deterministic process involving gene susceptibility, environmental factors, and gene function.

Area of Science:

  • Epigenetics
  • Cancer Biology
  • Genomics

Background:

  • DNA methylation alterations are hallmarks of cancer development.
  • Aberrant DNA methylation contributes to tumorigenesis by affecting tumor suppressor genes and gene expression.
  • The causes of aberrant DNA methylation are complex and multifactorial.

Purpose of the Study:

  • To review the technologies used to study DNA methylation.
  • To explore the endogenous and exogenous factors influencing de novo DNA methylation in cancer.
  • To discuss the deterministic mechanisms underlying aberrant DNA methylation in cancer.

Main Methods:

  • Review of current literature on DNA methylation technologies.
  • Analysis of studies investigating factors influencing DNA methylation.
  • Synthesis of evidence supporting deterministic mechanisms in cancer epigenetics.

Main Results:

  • Various technologies exist for studying DNA methylation patterns.
  • Intrinsic gene susceptibility, environmental factors, and gene function interplay to cause aberrant methylation.
  • Evidence suggests a deterministic, rather than stochastic, mechanism for de novo DNA methylation in cancer.

Conclusions:

  • Understanding the causes of aberrant DNA methylation is critical for cancer research.
  • The interplay of genetic and environmental factors highlights the complexity of epigenetic regulation in cancer.
  • Future research should focus on elucidating these deterministic mechanisms to develop targeted cancer therapies.